| 000 | 01661 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517174752.0 | ||
| 264 | 0 | _c20180626 | |
| 008 | 201806s 0 0 eng d | ||
| 022 | _a2326-6074 | ||
| 024 | 7 |
_a10.1158/2326-6066.CIR-17-0131 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aColbeck, Emily J | |
| 245 | 0 | 0 |
_aTreg Depletion Licenses T Cell-Driven HEV Neogenesis and Promotes Tumor Destruction. _h[electronic resource] |
| 260 |
_bCancer immunology research _c11 2017 |
||
| 300 |
_a1005-1015 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDendritic Cells _ximmunology |
| 650 | 0 | 4 |
_aEndothelium, Vascular _ximmunology |
| 650 | 0 | 4 | _aLymphocyte Depletion |
| 650 | 0 | 4 |
_aLymphocytes, Tumor-Infiltrating _ximmunology |
| 650 | 0 | 4 |
_aLymphotoxin beta Receptor _ximmunology |
| 650 | 0 | 4 | _aMethylcholanthrene |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNeoplasms _xchemically induced |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _ximmunology |
| 650 | 0 | 4 |
_aT-Lymphocytes, Regulatory _ximmunology |
| 700 | 1 | _aJones, Emma | |
| 700 | 1 | _aHindley, James P | |
| 700 | 1 | _aSmart, Kathryn | |
| 700 | 1 | _aSchulz, Ralph | |
| 700 | 1 | _aBrowne, Molly | |
| 700 | 1 | _aCutting, Scott | |
| 700 | 1 | _aWilliams, Anwen | |
| 700 | 1 | _aParry, Lee | |
| 700 | 1 | _aGodkin, Andrew | |
| 700 | 1 | _aWare, Carl F | |
| 700 | 1 | _aAger, Ann | |
| 700 | 1 | _aGallimore, Awen | |
| 773 | 0 |
_tCancer immunology research _gvol. 5 _gno. 11 _gp. 1005-1015 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/2326-6066.CIR-17-0131 _zAvailable from publisher's website |
| 999 |
_c27601747 _d27601747 |
||